These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1252 related articles for article (PubMed ID: 27620662)
1. Inhibiting adhesion events by Panax notoginseng saponins and Ginsenoside Rb1 protecting arteries via activation of Nrf2 and suppression of p38 - VCAM-1 signal pathway. Fan J; Liu D; He C; Li X; He F J Ethnopharmacol; 2016 Nov; 192():423-430. PubMed ID: 27620662 [TBL] [Abstract][Full Text] [Related]
2. Panax notoginseng saponins provide neuroprotection by regulating NgR1/RhoA/ROCK2 pathway expression, in vitro and in vivo. Shi X; Yu W; Yang T; Liu W; Zhao Y; Sun Y; Chai L; Gao Y; Dong B; Zhu L J Ethnopharmacol; 2016 Aug; 190():301-12. PubMed ID: 27288754 [TBL] [Abstract][Full Text] [Related]
3. Triptolide-induced hepatotoxicity can be alleviated when combined with Panax notoginseng saponins and Catapol. Zhou L; Zhou C; Feng Z; Liu Z; Zhu H; Zhou X J Ethnopharmacol; 2018 Mar; 214():232-239. PubMed ID: 29277608 [TBL] [Abstract][Full Text] [Related]
4. Panax notoginseng saponins attenuate atherosclerosis via reciprocal regulation of lipid metabolism and inflammation by inducing liver X receptor alpha expression. Fan JS; Liu DN; Huang G; Xu ZZ; Jia Y; Zhang HG; Li XH; He FT J Ethnopharmacol; 2012 Aug; 142(3):732-8. PubMed ID: 22683903 [TBL] [Abstract][Full Text] [Related]
5. Panax notoginseng saponins inhibit Zymosan A induced atherosclerosis by suppressing integrin expression, FAK activation and NF-κB translocation. Yuan Z; Liao Y; Tian G; Li H; Jia Y; Zhang H; Tan Z; Li X; Deng W; Liu K; Zhang Y J Ethnopharmacol; 2011 Oct; 138(1):150-5. PubMed ID: 21924337 [TBL] [Abstract][Full Text] [Related]
6. Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion. Huang XP; Ding H; Lu JD; Tang YH; Deng BX; Deng CQ Am J Chin Med; 2015; 43(7):1419-38. PubMed ID: 26477799 [TBL] [Abstract][Full Text] [Related]
8. Panax notoginseng saponins alleviate diabetic retinopathy by inhibiting retinal inflammation: Association with the NF-κB signaling pathway. Wang Y; Sun X; Xie Y; Du A; Chen M; Lai S; Wei X; Ji L; Wang C J Ethnopharmacol; 2024 Jan; 319(Pt 1):117135. PubMed ID: 37689326 [TBL] [Abstract][Full Text] [Related]
9. Hu S; Wu Y; Zhao B; Hu H; Zhu B; Sun Z; Li P; Du S Molecules; 2018 Oct; 23(11):. PubMed ID: 30373188 [TBL] [Abstract][Full Text] [Related]
10. Panax notoginseng saponins suppress lipopolysaccharide-induced barrier disruption and monocyte adhesion on bEnd.3 cells via the opposite modulation of Nrf2 antioxidant and NF-κB inflammatory pathways. Hu S; Liu T; Wu Y; Yang W; Hu S; Sun Z; Li P; Du S Phytother Res; 2019 Dec; 33(12):3163-3176. PubMed ID: 31468630 [TBL] [Abstract][Full Text] [Related]
11. Panax notoginseng saponins attenuate atherosclerosis in rats by regulating the blood lipid profile and an anti-inflammatory action. Zhang YG; Zhang HG; Zhang GY; Fan JS; Li XH; Liu YH; Li SH; Lian XM; Tang Z Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1238-44. PubMed ID: 18637019 [TBL] [Abstract][Full Text] [Related]
12. [Advances in pharmacological studies of Panax notoginseng saponins on brain ischemia-reperfusion injury]. Yang PF; Song XY; Chen NH Yao Xue Xue Bao; 2016 Jul; 51(7):1039-46. PubMed ID: 29896950 [TBL] [Abstract][Full Text] [Related]
13. Panax notogingseng saponins suppress RAGE/MAPK signaling and NF-kappaB activation in apolipoprotein-E-deficient atherosclerosis-prone mice. Dou L; Lu Y; Shen T; Huang X; Man Y; Wang S; Li J Cell Physiol Biochem; 2012; 29(5-6):875-82. PubMed ID: 22613987 [TBL] [Abstract][Full Text] [Related]
14. Panax notoginseng saponin is superior to aspirin in inhibiting platelet adhesion to injured endothelial cells through COX pathway in vitro. Wang MM; Xue M; Xu YG; Miao Y; Kou N; Yang L; Zhang Y; Shi DZ Thromb Res; 2016 May; 141():146-52. PubMed ID: 27043068 [TBL] [Abstract][Full Text] [Related]
15. Panax notoginseng Saponins protect auditory cells against cisplatin‑induced ototoxicity by inducing the AKT/Nrf2 signaling‑mediated redox pathway. Fei B; Liu Z; Xie L; Lv L; Zhu W; Liu J; Dai Y; She W Mol Med Rep; 2020 Oct; 22(4):3533-3540. PubMed ID: 32945421 [TBL] [Abstract][Full Text] [Related]
16. [Effects of panax notoginseng saponins on expression of intercellular adhesion molecule-1 in human umbilical vein endothelial cells injury induced by oxidized low-density lipoprotein]. Qin JH; Zhu LQ; Cui W Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Dec; 28(12):1096-9. PubMed ID: 19317166 [TBL] [Abstract][Full Text] [Related]
17. [Major hypoglycemic ingredients of Panax notoginseng saponins for treating diabetes]. Zhong ZD; Wang CM; Wang W; Shen L; Chen ZH Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Mar; 45(2):235-9. PubMed ID: 24749347 [TBL] [Abstract][Full Text] [Related]
18. [Protective effects and underlying mechanisms of Panax notoginseng saponins against SH-SY5Y cell apoptosis induced by 6-hydroxydopamine]. Wang MX; Zhao JY; Sun DM; Meng XB; Sun GB; Sun XB Yao Xue Xue Bao; 2016 Jun; 51(6):898-906. PubMed ID: 29879342 [TBL] [Abstract][Full Text] [Related]
19. Anti-diabetic potential of Panax notoginseng saponins (PNS): a review. Uzayisenga R; Ayeka PA; Wang Y Phytother Res; 2014 Apr; 28(4):510-6. PubMed ID: 23846979 [TBL] [Abstract][Full Text] [Related]
20. Panax notoginseng reduces atherosclerotic lesions in ApoE-deficient mice and inhibits TNF-alpha-induced endothelial adhesion molecule expression and monocyte adhesion. Wan JB; Lee SM; Wang JD; Wang N; He CW; Wang YT; Kang JX J Agric Food Chem; 2009 Aug; 57(15):6692-7. PubMed ID: 19722574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]